Table 4.

T-tests: significance of pre-/post-differences in outcome measures—patient-reported/subjective data.

Variable	Overall pre-/post: last visit vs. baseline	Categorized: 1–5 visits vs. baseline	Categorized: 6-10 visits vs. baseline	Categorized: 11–15 visits vs. baseline	Categorized: 16–30 visits vs. baseline
Vibratory sensation—right foot (seconds)	2.99 (p < 0.001)	2.67	1.86	1.27	4.32
Vibratory sensation—left foot (seconds)	3.46 (p < 0.001)	3.67	1.29	2.43	4.00
How are you feeling?	0.54 (p = 0.011)	−0.45	1.18	0.50	0.79
How is your overall health?	0.69 (p < 0.001)	−0.34	0.18	0.67	1.29
How is your diabetes-related pain?	−0.52 (p = 0.131)	0.00	−0.85	0.33	−0.33
Diabetes pain interference w/ADLs?	0.01 (p = 0.977)	−1.00	−0.70	0.57	−1.05
Overall improvement since starting MII?*	25.38% (p < 0.001)	7.17%	6.15%	23.91%	38.88%
Physical activity change? (since last treatment)	NS	NS	NS	NS	NS
Energy change? (since last treatment)	NS	NS	NS	NS	NS
Neuropathy change? (since last treatment)	NS	NS	NS	NS	NS
Sleep pattern/quality change? (since last treatment)	NS	NS	NS	NS	NS
Vision change? (since last treatment)	NS	NS	NS	NS	NS

^*MII, Microburst Insulin Infusion therapy. Bold p-values indicate statistically significant coefficients.